{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T14:34:33Z","timestamp":1793025273614,"version":"4.5.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T00:00:00Z","timestamp":1576022400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Chronic inflammation and fibrosis can result from inappropriately activated immune responses that are mediated by macrophages. Macrophages can acquire memory-like characteristics in response to antigen exposure. Here, we show the effect of BCG or low-dose LPS stimulation on macrophage phenotype, cytokine production, chromatin and metabolic modifications. Low-dose LPS training alleviates fibrosis and inflammation in a mouse model of systemic sclerosis (SSc), whereas BCG-training exacerbates disease in this model. Adoptive transfer of low-dose LPS-trained or BCG-trained macrophages also has beneficial or harmful effects, respectively. Furthermore, coculture with low-dose LPS trained macrophages reduces the fibro-inflammatory profile of fibroblasts from mice and patients with SSc, indicating that trained immunity might be a phenomenon that can be targeted to treat SSc and other autoimmune and inflammatory fibrotic disorders.<\/jats:p>","DOI":"10.1038\/s41467-019-13636-x","type":"journal-article","created":{"date-parts":[[2019,12,11]],"date-time":"2019-12-11T07:44:58Z","timestamp":1576050298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":154,"title":["Trained immunity modulates inflammation-induced fibrosis"],"prefix":"10.1038","volume":"10","author":[{"given":"Mohamed","family":"Jeljeli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0389-7939","authenticated-orcid":false,"given":"Luiza Gama Coelho","family":"Riccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludivine","family":"Doridot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Ch\u00eane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8211-2556","authenticated-orcid":false,"given":"Carole","family":"Nicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Chouzenoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Deletang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-0002","authenticated-orcid":false,"given":"Yannick","family":"Allanore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Kavian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Batteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,11]]},"reference":[{"key":"13636_CR1","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov, R. Origin and physiological roles of inflammation. Nature 454, 428\u2013435 (2008).","journal-title":"Nature"},{"key":"13636_CR2","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","volume":"30","author":"TA Wynn","year":"2010","unstructured":"Wynn, T. A. & Barron, L. Macrophages: master regulators of inflammation and fibrosis. Semin. Liver Dis. 30, 245\u2013257 (2010).","journal-title":"Semin. Liver Dis."},{"key":"13636_CR3","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn, T. A. & Ramalingam, T. R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat. Med. 18, 1028\u20131040 (2012).","journal-title":"Nat. Med."},{"key":"13636_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2016.48","volume":"12","author":"X-M Meng","year":"2016","unstructured":"Meng, X.-M., Nikolic-Paterson, D. J. & Lan, H. Y. TGF-\u03b2: the master regulator of fibrosis. Nat. Rev. Nephrol. 12, 325\u2013338 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"13636_CR5","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.ajpath.2013.06.034","volume":"183","author":"ML Novak","year":"2013","unstructured":"Novak, M. L. & Koh, T. J. Phenotypic transitions of macrophages orchestrate tissue repair. Am. J. Pathol. 183, 1352\u20131363 (2013).","journal-title":"Am. J. Pathol."},{"key":"13636_CR6","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.chom.2017.02.003","volume":"21","author":"MG Netea","year":"2017","unstructured":"Netea, M. G. & van der Meer, J. W. M. Trained immunity: an ancient way of remembering. Cell Host Microbe 21, 297\u2013300 (2017).","journal-title":"Cell Host Microbe"},{"key":"13636_CR7","doi-asserted-by":"publisher","first-page":"aaf1098","DOI":"10.1126\/science.aaf1098","volume":"352","author":"MG Netea","year":"2016","unstructured":"Netea, M. G. et al. Trained immunity: a program of innate immune memory in health and disease. Science 352, aaf1098 (2016).","journal-title":"Science"},{"key":"13636_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.chom.2012.06.006","volume":"12","author":"J Quintin","year":"2012","unstructured":"Quintin, J. et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12, 223\u2013232 (2012).","journal-title":"Cell Host Microbe"},{"key":"13636_CR9","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","volume":"17","author":"RJW Arts","year":"2016","unstructured":"Arts, R. J. W. et al. Immunometabolic pathways in BCG-induced trained immunity. Cell Rep. 17, 2562\u20132571 (2016).","journal-title":"Cell Rep."},{"key":"13636_CR10","doi-asserted-by":"publisher","first-page":"17537","DOI":"10.1073\/pnas.1202870109","volume":"109","author":"J Kleinnijenhuis","year":"2012","unstructured":"Kleinnijenhuis, J. et al. Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc. Natl Acad. Sci. USA 109, 17537\u201317542 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13636_CR11","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1159\/000355628","volume":"6","author":"J Kleinnijenhuis","year":"2014","unstructured":"Kleinnijenhuis, J. et al. Long-lasting effects of BCG vaccination on both heterologous Th1\/Th17 responses and innate trained immunity. J. Innate Immun. 6, 152\u2013158 (2014).","journal-title":"J. Innate Immun."},{"key":"13636_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.it.2009.07.009","volume":"30","author":"SK Biswas","year":"2009","unstructured":"Biswas, S. K. & Lopez-Collazo, E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 30, 475\u2013487 (2009).","journal-title":"Trends Immunol."},{"key":"13636_CR13","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nm0697-678","volume":"3","author":"WD D\u00f6cke","year":"1997","unstructured":"D\u00f6cke, W. D. et al. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat. Med. 3, 678\u2013681 (1997).","journal-title":"Nat. Med."},{"key":"13636_CR14","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.4049\/jimmunol.160.8.3729","volume":"160","author":"A Shnyra","year":"1998","unstructured":"Shnyra, A., Brewington, R., Alipio, A., Amura, C. & Morrison, D. C. Reprogramming of lipopolysaccharide-primed macrophages is controlled by a counterbalanced production of IL-10 and IL-12. J. Immunol. 160, 3729\u20133736 (1998).","journal-title":"J. Immunol."},{"key":"13636_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ni.3398","volume":"17","author":"S-C Cheng","year":"2016","unstructured":"Cheng, S.-C. et al. Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis. Nat. Immunol. 17, 406\u2013413 (2016).","journal-title":"Nat. Immunol."},{"key":"13636_CR16","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.cell.2016.09.034","volume":"167","author":"B Novakovic","year":"2016","unstructured":"Novakovic, B. et al. \u03b2-glucan reverses the epigenetic state of LPS-induced immunological tolerance. Cell 167, 1354\u20131368.e14 (2016).","journal-title":"Cell"},{"key":"13636_CR17","doi-asserted-by":"publisher","first-page":"1251086","DOI":"10.1126\/science.1251086","volume":"345","author":"S Saeed","year":"2014","unstructured":"Saeed, S. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345, 1251086 (2014).","journal-title":"Science"},{"key":"13636_CR18","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.smim.2016.09.002","volume":"28","author":"RJW Arts","year":"2016","unstructured":"Arts, R. J. W., Joosten, L. A. B. & Netea, M. G. Immunometabolic circuits in trained immunity. Semin. Immunol. 28, 425\u2013430 (2016).","journal-title":"Semin. Immunol."},{"key":"13636_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1189\/jlb.3MR0316-118RR","volume":"101","author":"JJ Seeley","year":"2017","unstructured":"Seeley, J. J. & Ghosh, S. Molecular mechanisms of innate memory and tolerance to LPS. J. Leukoc. Biol. 101, 107\u2013119 (2017).","journal-title":"J. Leukoc. Biol."},{"key":"13636_CR20","doi-asserted-by":"publisher","first-page":"298","DOI":"10.3389\/fimmu.2018.00298","volume":"9","author":"RJW Arts","year":"2018","unstructured":"Arts, R. J. W., Joosten, L. A. B. & Netea, M. G. The potential role of trained immunity in autoimmune and autoinflammatory disorders. Front. Immunol. 9, 298 (2018).","journal-title":"Front. Immunol."},{"key":"13636_CR21","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Dis. Primers 1, 15002 (2015).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"13636_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/BOR.0000000000000218","volume":"27","author":"JJ Chia","year":"2015","unstructured":"Chia, J. J. & Lu, T. T. Update on macrophages and innate immunity in scleroderma. Curr. Opin. Rheumatol. 27, 530\u2013536 (2015).","journal-title":"Curr. Opin. Rheumatol."},{"key":"13636_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1007\/s12016-017-8606-7","volume":"53","author":"M Morell","year":"2017","unstructured":"Morell, M., Varela, N. & Mara\u00f1\u00f3n, C. Myeloid populations in systemic autoimmune diseases. Clin. Rev. Allergy Immunol. 53, 198\u2013218 (2017).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"13636_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11926-015-0554-8","volume":"18","author":"G Stifano","year":"2016","unstructured":"Stifano, G. & Christmann, R. B. Macrophage involvement in systemic sclerosis: do we need more evidence? Curr. Rheumatol. Rep. 18, 2 (2016).","journal-title":"Curr. Rheumatol. Rep."},{"key":"13636_CR25","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.autrev.2008.12.019","volume":"8","author":"H Waldner","year":"2009","unstructured":"Waldner, H. The role of innate immune responses in autoimmune disease development. Autoimmun. Rev. 8, 400\u2013404 (2009).","journal-title":"Autoimmun. Rev."},{"key":"13636_CR26","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.humpath.2015.08.004","volume":"46","author":"M Hu","year":"2015","unstructured":"Hu, M. et al. Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer. Hum. Pathol. 46, 1872\u20131880 (2015).","journal-title":"Hum. Pathol."},{"key":"13636_CR27","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.it.2004.09.015","volume":"25","author":"A Mantovani","year":"2004","unstructured":"Mantovani, A. et al. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 25, 677\u2013686 (2004).","journal-title":"Trends Immunol."},{"key":"13636_CR28","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.bbadis.2012.11.004","volume":"1832","author":"H Sahin","year":"2013","unstructured":"Sahin, H. & Wasmuth, H. E. Chemokines in tissue fibrosis. Biochim. Biophys. Acta 1832, 1041\u20131048 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"13636_CR29","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1016\/j.ajpath.2011.07.048","volume":"179","author":"S Maeda","year":"2011","unstructured":"Maeda, S. et al. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production. Am. J. Pathol. 179, 2360\u20132369 (2011).","journal-title":"Am. J. Pathol."},{"key":"13636_CR30","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.immuni.2015.05.009","volume":"42","author":"P Conde","year":"2015","unstructured":"Conde, P. et al. DC-SIGN(+) macrophages control the induction of transplantation tolerance. Immunity 42, 1143\u20131158 (2015).","journal-title":"Immunity"},{"key":"13636_CR31","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3389\/fimmu.2014.00514","volume":"5","author":"P Italiani","year":"2014","unstructured":"Italiani, P. & Boraschi, D. From monocytes to M1\/M2 macrophages: phenotypical vs. functional differentiation. Front. Immunol. 5, 514 (2014).","journal-title":"Front. Immunol."},{"key":"13636_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1177\/0885066612467162","volume":"29","author":"T Wang","year":"2014","unstructured":"Wang, T. et al. Subsequent infections in survivors of sepsis: epidemiology and outcomes. J. Intensive Care Med. 29, 87\u201395 (2014).","journal-title":"J. Intensive Care Med."},{"key":"13636_CR33","first-page":"1202","volume":"19","author":"O Ishikawa","year":"1992","unstructured":"Ishikawa, O. & Ishikawa, H. Macrophage infiltration in the skin of patients with systemic sclerosis. J. Rheumatol. 19, 1202\u20131206 (1992).","journal-title":"J. Rheumatol."},{"key":"13636_CR34","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","volume":"185","author":"A Yoshizaki","year":"2010","unstructured":"Yoshizaki, A. et al. Cell adhesion molecules regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model. J. Immunol. 185, 2502\u20132515 (2010).","journal-title":"J. Immunol."},{"key":"13636_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga, J. & Abraham, D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117, 557\u2013567 (2007).","journal-title":"J. Clin. Invest."},{"key":"13636_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13069-015-0028-7","volume":"8","author":"R Lee","year":"2015","unstructured":"Lee, R. et al. Enhanced chemokine-receptor expression, function, and signaling in healthy African American and scleroderma-patient monocytes are regulated by caveolin-1. Fibrogenes. Tissue Repair 8, 11 (2015).","journal-title":"Fibrogenes. Tissue Repair"},{"key":"13636_CR37","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1007\/s10067-017-3597-6","volume":"36","author":"A Lescoat","year":"2017","unstructured":"Lescoat, A. et al. CD16-positive circulating monocytes and fibrotic manifestations of systemic sclerosis. Clin. Rheumatol. 36, 1649\u20131654 (2017).","journal-title":"Clin. Rheumatol."},{"key":"13636_CR38","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s13075-018-1545-8","volume":"20","author":"F Weigold","year":"2018","unstructured":"Weigold, F. et al. Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis. Arthritis Res. Ther. 20, 52 (2018).","journal-title":"Arthritis Res. Ther."},{"key":"13636_CR39","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1164\/rccm.201010-1719OC","volume":"184","author":"MA Gibbons","year":"2011","unstructured":"Gibbons, M. A. et al. Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am. J. Respir. Crit. Care Med. 184, 569\u2013581 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"13636_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1465-9921-6-93","volume":"6","author":"D Hartl","year":"2005","unstructured":"Hartl, D. et al. A role for MCP-1\/CCR2 in interstitial lung disease in children. Respir. Res. 6, 93 (2005).","journal-title":"Respir. Res."},{"key":"13636_CR41","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0002-9440(10)63292-0","volume":"165","author":"K Kitagawa","year":"2004","unstructured":"Kitagawa, K. et al. Blockade of CCR2 ameliorates progressive fibrosis in kidney. Am. J. Pathol. 165, 237\u2013246 (2004).","journal-title":"Am. J. Pathol."},{"key":"13636_CR42","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.4049\/jimmunol.167.8.4368","volume":"167","author":"BB Moore","year":"2001","unstructured":"Moore, B. B. et al. Protection from pulmonary fibrosis in the absence of CCR2 signaling. J. Immunol. Baltim. 167, 4368\u20134377 (2001).","journal-title":"J. Immunol. Baltim."},{"key":"13636_CR43","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/path.1667","volume":"204","author":"T Okuma","year":"2004","unstructured":"Okuma, T. et al. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. J. Pathol. 204, 594\u2013604 (2004).","journal-title":"J. Pathol."},{"key":"13636_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/hep.22952","volume":"50","author":"E Seki","year":"2009","unstructured":"Seki, E. et al. CCR2 promotes hepatic fibrosis in mice. Hepatology 50, 185\u2013197 (2009).","journal-title":"Hepatology"},{"key":"13636_CR45","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1038\/cti.2017.8","volume":"6","author":"S Wolf","year":"2017","unstructured":"Wolf, S., Johnson, S., Perwitasari, O., Mahalingam, S. & Tripp, R. A. Targeting the pro-inflammatory factor CCL2 (MCP-1) with Bindarit for influenza A (H7N9) treatment. Clin. Transl. Immunol. 6, e135 (2017).","journal-title":"Clin. Transl. Immunol."},{"key":"13636_CR46","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1182\/blood-2009-12-258186","volume":"117","author":"L S\u00e1nchez-Mart\u00edn","year":"2011","unstructured":"S\u00e1nchez-Mart\u00edn, L. et al. The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. Blood 117, 88\u201397 (2011).","journal-title":"Blood"},{"key":"13636_CR47","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1002\/art.27428","volume":"62","author":"C Tanaka","year":"2010","unstructured":"Tanaka, C. et al. Inducible costimulator ligand regulates bleomycin-induced lung and skin fibrosis in a mouse model independently of the inducible costimulator\/inducible costimulator ligand pathway. Arthritis Rheum. 62, 1723\u20131732 (2010).","journal-title":"Arthritis Rheum."},{"key":"13636_CR48","doi-asserted-by":"publisher","first-page":"8385","DOI":"10.1073\/pnas.1500956112","volume":"112","author":"N Cox","year":"2015","unstructured":"Cox, N., Pilling, D. & Gomer, R. H. DC-SIGN activation mediates the differential effects of SAP and CRP on the innate immune system and inhibits fibrosis in mice. Proc. Natl Acad. Sci. USA 112, 8385\u20138390 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"13636_CR49","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1136\/thx.2005.056317","volume":"61","author":"K Nakagome","year":"2006","unstructured":"Nakagome, K. et al. In vivo IL-10 gene delivery attenuates bleomycin induced pulmonary fibrosis by inhibiting the production and activation of TGF-beta in the lung. Thorax 61, 886\u2013894 (2006).","journal-title":"Thorax"},{"key":"13636_CR50","doi-asserted-by":"crossref","unstructured":"Basu, J., Shin, D.-M. & Jo, E.-K. Mycobacterial signaling through toll-like receptors. Front. Cell. Infect. Microbiol. 2, 145 (2012).","DOI":"10.3389\/fcimb.2012.00145"},{"key":"13636_CR51","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nri2079","volume":"7","author":"LAJ O\u2019Neill","year":"2007","unstructured":"O\u2019Neill, L. A. J. & Bowie, A. G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7, 353\u2013364 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"13636_CR52","doi-asserted-by":"crossref","unstructured":"Bhattacharyya, S. et al. TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung. JCI Insight 3, 98850 (2018).","DOI":"10.1172\/jci.insight.98850"},{"key":"13636_CR53","doi-asserted-by":"publisher","first-page":"R136","DOI":"10.1186\/ar4598","volume":"16","author":"G Stifano","year":"2014","unstructured":"Stifano, G. et al. Chronic Toll-like receptor 4 stimulation in skin induces inflammation, macrophage activation, transforming growth factor beta signature gene expression, and fibrosis. Arthritis Res. Ther. 16, R136 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"13636_CR54","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/cimm.2000.1687","volume":"204","author":"E Song","year":"2000","unstructured":"Song, E. et al. Influence of alternatively and classically activated macrophages on fibrogenic activities of human fibroblasts. Cell. Immunol. 204, 19\u201328 (2000).","journal-title":"Cell. Immunol."},{"key":"13636_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/srep28261","volume":"6","author":"JZ Kechagia","year":"2016","unstructured":"Kechagia, J. Z., Ezra, D. G., Burton, M. J. & Bailly, M. Fibroblasts profiling in scarring trachoma identifies IL-6 as a functional component of a fibroblast-macrophage pro-fibrotic and pro-inflammatory feedback loop. Sci. Rep. 6, 28261 (2016).","journal-title":"Sci. Rep."},{"key":"13636_CR56","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.immuni.2015.09.013","volume":"43","author":"TE O\u2019Sullivan","year":"2015","unstructured":"O\u2019Sullivan, T. E., Sun, J. C. & Lanier, L. L. Natural killer cell memory. Immunity 43, 634\u2013645 (2015).","journal-title":"Immunity"},{"key":"13636_CR57","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.it.2017.03.005","volume":"38","author":"I Martinez-Gonzalez","year":"2017","unstructured":"Martinez-Gonzalez, I., Math\u00e4, L., Steer, C. A. & Takei, F. Immunological memory of group 2 innate lymphoid cells. Trends Immunol. 38, 423\u2013431 (2017).","journal-title":"Trends Immunol."},{"key":"13636_CR58","doi-asserted-by":"crossref","unstructured":"Li, H., You, H., Fan, X. & Jia, J. Hepatic macrophages in liver fibrosis: pathogenesis and potential therapeutic targets. BMJ Open Gastroenterol. 3, e000079 (2016).","DOI":"10.1136\/bmjgast-2016-000079"},{"key":"13636_CR59","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","volume":"66","author":"F Tacke","year":"2017","unstructured":"Tacke, F. Targeting hepatic macrophages to treat liver diseases. J. Hepatol. 66, 1300\u20131312 (2017).","journal-title":"J. Hepatol."},{"key":"13636_CR60","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1002\/hep.24315","volume":"53","author":"JA Thomas","year":"2011","unstructured":"Thomas, J. A. et al. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology 53, 2003\u20132015 (2011).","journal-title":"Hepatology"},{"key":"13636_CR61","doi-asserted-by":"publisher","first-page":"R168","DOI":"10.1186\/ar4352","volume":"15","author":"A Fran\u00e7ois","year":"2013","unstructured":"Fran\u00e7ois, A. et al. B lymphocytes and B-cell activating factor promote collagen and profibrotic markers expression by dermal fibroblasts in systemic sclerosis. Arthritis Res. Ther. 15, R168 (2013).","journal-title":"Arthritis Res. Ther."},{"key":"13636_CR62","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1465-9921-6-103","volume":"6","author":"C Vancheri","year":"2005","unstructured":"Vancheri, C. et al. Interaction between human lung fibroblasts and T-lymphocytes prevents activation of CD4+ cells. Respir. Res. 6, 103 (2005).","journal-title":"Respir. Res."},{"key":"13636_CR63","doi-asserted-by":"publisher","first-page":"698","DOI":"10.4049\/jimmunol.179.1.698","volume":"179","author":"Y Matsushita","year":"2007","unstructured":"Matsushita, Y. et al. Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice. J. Immunol. 179, 698\u2013707 (2007).","journal-title":"J. Immunol."},{"key":"13636_CR64","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2249.1994.tb05517.x","volume":"98","author":"K Josefsen","year":"1994","unstructured":"Josefsen, K., Nielsen, H., Lorentzen, S., Damsbo, P. & Buschard, K. Circulating monocytes are activated in newly diagnosed type 1 diabetes mellitus patients. Clin. Exp. Immunol. 98, 489\u2013493 (1994).","journal-title":"Clin. Exp. Immunol."},{"key":"13636_CR65","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1111\/imcb.1025","volume":"96","author":"MC Gjelstrup","year":"2018","unstructured":"Gjelstrup, M. C. et al. Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis. Immunol. Cell Biol. 96, 160\u2013174 (2018).","journal-title":"Immunol. Cell Biol."},{"key":"13636_CR66","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00005-010-0093-y","volume":"58","author":"Y Li","year":"2010","unstructured":"Li, Y., Lee, P. Y. & Reeves, W. H. Monocyte and macrophage abnormalities in systemic lupus erythematosus. Arch. Immunol. Ther. Exp. (Warz.) 58, 355\u2013364 (2010).","journal-title":"Arch. Immunol. Ther. Exp. (Warz.)"},{"key":"13636_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-10-35","volume":"10","author":"DY Vogel","year":"2013","unstructured":"Vogel, D. Y. et al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. J. Neuroinflammation 10, 35 (2013).","journal-title":"J. Neuroinflammation"},{"key":"13636_CR68","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.2337\/db12-0099","volume":"61","author":"AK Alkanani","year":"2012","unstructured":"Alkanani, A. K. et al. Dysregulated Toll-like receptor-induced interleukin-1\u03b2 and interleukin-6 responses in subjects at risk for the development of type 1 diabetes. Diabetes 61, 2525\u20132533 (2012).","journal-title":"Diabetes"},{"key":"13636_CR69","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1136\/ard.59.4.283","volume":"59","author":"F Steinbach","year":"2000","unstructured":"Steinbach, F. et al. Monocytes from systemic lupus erythematous patients are severely altered in phenotype and lineage flexibility. Ann. Rheum. Dis. 59, 283\u2013288 (2000).","journal-title":"Ann. Rheum. Dis."},{"key":"13636_CR70","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1046\/j.1365-2249.1996.d01-820.x","volume":"106","author":"F Liot\u00e9","year":"1996","unstructured":"Liot\u00e9, F., Boval-Boizard, B., Weill, D., Kuntz, D. & Wautier, J. L. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin. Exp. Immunol. 106, 13\u201319 (1996).","journal-title":"Clin. Exp. Immunol."},{"key":"13636_CR71","first-page":"6626","volume":"7","author":"S Zhang","year":"2014","unstructured":"Zhang, S. et al. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN\/LPS induced acute liver failure through TLR4 signaling pathway. Int. J. Clin. Exp. Pathol. 7, 6626\u20136634 (2014).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"13636_CR72","doi-asserted-by":"crossref","unstructured":"Bartosh, T. J. & Ylostalo, J. H. Macrophage inflammatory assay. Bio Protoc. 4, e1180 (2014).","DOI":"10.21769\/BioProtoc.1180"},{"key":"13636_CR73","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1471-2172-14-6","volume":"14","author":"C Wang","year":"2013","unstructured":"Wang, C. et al. Characterization of murine macrophages from bone marrow, spleen and peritoneum. BMC Immunol. 14, 6 (2013).","journal-title":"BMC Immunol."},{"key":"13636_CR74","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jim.2011.08.013","volume":"373","author":"AL Brubaker","year":"2011","unstructured":"Brubaker, A. L., Schneider, D. F., Palmer, J. L., Faunce, D. E. & Kovacs, E. J. An improved cell isolation method for flow cytometric and functional analyses of cutaneous wound leukocytes. J. Immunol. Methods 373, 161\u2013166 (2011).","journal-title":"J. Immunol. Methods"},{"key":"13636_CR75","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2017.12.031","volume":"172","author":"E Kaufmann","year":"2018","unstructured":"Kaufmann, E. et al. BCG educates hematopoietic stem cells to generate protective innate immunity against tuberculosis. Cell 172, 176\u2013190.e19 (2018).","journal-title":"Cell"},{"key":"13636_CR76","doi-asserted-by":"publisher","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","volume":"182","author":"A Servettaz","year":"2009","unstructured":"Servettaz, A. et al. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J. Immunol. 182, 5855\u20135864 (2009).","journal-title":"J. Immunol."},{"key":"13636_CR77","doi-asserted-by":"publisher","first-page":"3430","DOI":"10.1002\/art.34534","volume":"64","author":"N Kavian","year":"2012","unstructured":"Kavian, N. et al. Reactive oxygen species-mediated killing of activated fibroblasts by arsenic trioxide ameliorates fibrosis in a murine model of systemic sclerosis. Arthritis Rheum. 64, 3430\u20133440 (2012).","journal-title":"Arthritis Rheum."},{"key":"13636_CR78","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1002\/art.34354","volume":"64","author":"N Kavian","year":"2012","unstructured":"Kavian, N. et al. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor \u03b2 in the skin of mice with scleroderma-like features and prevents the development of the disease. Arthritis Rheum. 64, 1990\u20132000 (2012).","journal-title":"Arthritis Rheum."},{"key":"13636_CR79","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/0003-9861(61)90291-0","volume":"93","author":"JF Woessner","year":"1961","unstructured":"Woessner, J. F. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch. Biochem. Biophys. 93, 440\u2013447 (1961).","journal-title":"Arch. Biochem. Biophys."},{"key":"13636_CR80","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ki.1996.186","volume":"49","author":"V Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat, V. et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 49, 1304\u20131313 (1996).","journal-title":"Kidney Int."},{"key":"13636_CR81","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/978-1-61779-527-5_12","volume":"844","author":"S Manzanero","year":"2012","unstructured":"Manzanero, S. Generation of mouse bone marrow-derived macrophages. Methods Mol. Biol. 844, 177\u2013181 (2012).","journal-title":"Methods Mol. Biol."},{"key":"13636_CR82","first-page":"pdb.prot5080","volume":"2008","author":"J Weischenfeldt","year":"2008","unstructured":"Weischenfeldt, J. & Porse, B. Bone marrow-derived macrophages (BMM): isolation and applications. CSH Protoc. 2008, pdb.prot5080 (2008).","journal-title":"CSH Protoc."},{"key":"13636_CR83","doi-asserted-by":"publisher","first-page":"4048235","DOI":"10.1155\/2016\/4048235","volume":"2016","author":"L Ch\u00e1vez-Gal\u00e1n","year":"2016","unstructured":"Ch\u00e1vez-Gal\u00e1n, L., Vesin, D., Martinvalet, D., Garcia, I. & Low Dose, B. C. G. Infection as a model for macrophage activation maintaining cell viability. J. Immunol. Res. 2016, 4048235 (2016).","journal-title":"J. Immunol. Res."},{"key":"13636_CR84","doi-asserted-by":"publisher","first-page":"e1002526","DOI":"10.1371\/journal.pcbi.1002526","volume":"8","author":"Y Fu","year":"2012","unstructured":"Fu, Y. et al. Network topologies and dynamics leading to endotoxin tolerance and priming in innate immune cells. PLoS Comput. Biol. 8, e1002526 (2012).","journal-title":"PLoS Comput. Biol."},{"key":"13636_CR85","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1074\/jbc.M112.424390","volume":"288","author":"H Deng","year":"2013","unstructured":"Deng, H., Maitra, U., Morris, M. & Li, L. Molecular mechanism responsible for the priming of macrophage activation. J. Biol. Chem. 288, 3897\u20133906 (2013).","journal-title":"J. Biol. Chem."},{"key":"13636_CR86","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen, F. et al. classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheumatol. 65, 2737\u20132747 (2013).","journal-title":"Arthritis Rheumatol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13636-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T17:36:51Z","timestamp":1695490611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-019-13636-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,11]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["13636"],"URL":"https:\/\/doi.org\/10.1038\/s41467-019-13636-x","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,11]]},"assertion":[{"value":"1 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5670"}}